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Abstract 
Review on PRXL2C, with data on DNA, on the 
protein encoded, and where the gene is implicated. 
Keywords 
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Overexpression; Cancer; Gastric cancer; Attention-
deficit/hyperactivity disorder 
Identity 
Other names: C9orf21, AAED1 
HGNC (Hugo): AAED1 
Location: 9q22.33 
DNA/RNA 
Description 
Six exons, four splice forms, one of which codes for 
a protein: 
Transcription 
Coding transcript: 2863bp 
Protein 
Description 
A selenoprotein is a protein containing 
selenocysteines (Sec), with an atom of selenium 
SHE taking the place of the sulfur SH of the cysteine. 
Decoding of UGA into a selenocysteine (Sec) is 
alternative to the stop signal in the canonical genetic 
code.  
The human selenoproteins (SelU family) are 
composed of three Cys-containing members, one of 
which being PRXL2C (Ensembl 
ENSG00000158122) (Castellano et al., 2004). 
PRXL2C amino acids 68-71 are: CYIC, a CXXC 
motif. According to InterPro 
http://www.ebi.ac.uk/interpro/protein/Q7RTV5, 
PRXL2C signature matches with thioredoxin-like 
superfamily in amino acids 35-135 (or 21-90) (with 
a thioredoxin CXXC motif at aa 68-71 (CYIC); the 
two cysteines can forms a disulfide bond), and also 
matches with peroxiredoxin-like 2A/B/C in aa 86-
196 (or 40-150). Peroxiredoxins and thioredoxins 
are involved in oxidation-reduction process 
(antioxidants). Peroxiredoxins form a family of thiol 
oxidoreductases and play a role in peroxides 
detoxification (see Figure2). A peroxidatic cysteine 
reduces the peroxide to water. Thioredoxin system 
reduce peroxiredoxins restoring to them their 
catalytically active form (West et al., 2018). 
Expression 
PRXL2C is widely expressed (The Human Protein 
Atlas). 
Figure 1 PRXL2C gene
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Figure 2 Peroxides detoxification by Peroxiredoxins motifs -C-X-X-C- 
 
Function 
Aaed1 was found to be one of the few primitive 
endoderm transition markers in preimplantation 
mouse embryos (Gerovska and Arauzo-Bravo, 
2016). 
Mutations 
Somatic 
According to Cosmic 
Glioma astrocytoma grade IV amino acid (aa) 
mutation: p.V91A from CDS mutation c.272T>C 
Papillary thyroid carcinomas aa mutation p.I81S 
(c.242T>G)  
Thyroid carcinomas NOS aa mutations: p.V95L 
(c.283G>T); p.G183V (c.548G>T)  
Lung small cell carcinoma aa mutation: p.E136K 
(c.406G>A) (Rudin et al. 2012)  
Lung adenocarcinoma aa mutations: p.H145N 
(c.433C>A) (Imielinski et al. 2012); p.S152L 
(c.455C>T)  
Skin melanoma aa mutations: p.M131I (c.393G>A); 
p.S148L (c.443C>T); p.W159* (c.476G>A)  
Colon adenocarcinoma aa mutations: p.E76D 
(c.228G>T); p.L110Q (c.329T>A) (Giannakis et al. 
2016); p.S143I (c.428G>T) (Giannakis et al. 2016); 
p.Q208H (c.624G>T) (Wood et al. 2007); p.P221H 
(c.662C>A)  
Duodenum adenoma aa mutations: p.K201N 
(c.603A>C) (Yachida et al. 2016); p.T218A 
(c.652A>G) (Yachida et al. 2016)  
Prostate adenocarcinoma aa mutation: p.H214R 
(c.641A>G) 
Implicated in 
Gastric cancer 
 (AhpC/TSA antioxidant enzyme domain containing 
1), which is upregulated in gastric  
 
 
cancer cells. Silencing of PRXL2C inhibited cancer 
cell proliferation in vitro in gastric cancer cell lines. 
Possibly though MAPK signaling, PRXL2C 
upregulates HIF1A (hypoxia inducible factor 1 
subunit alpha), a transcriptional activator of many 
genes, including glycolytic enzymes and glucose 
transporters in aerobic glycolysis (Zhang et al., 
2018). 
Renal cancer 
PRXL2C High expression is related with an 
unfavourable prognosis according to the Human 
Protein Atlas 
https://www.proteinatlas.org/ENSG00000158122-
AAED1/pathology 
 Attention-deficit/hyperactivity 
disorder (ADHD) 
A rare variant of PRXL2C (rs151326868) amino 
acid p.H200D (c.598C>G) was found to segregate 
with ADHD in one of the families with an apparent 
dominant inheritance that was studied (Corominas et 
al., 2018).  
PRXL2C binds PICK1 (Protein Kinase C-Alpha-
Binding Protein) and PICK1 binds SLC6A3 (solute 
carrier family 6 member 3, also known as DAT, the 
dopamine transporter 1), regulating SLC6A3 
trafficking in presynaptic sites of dopaminergic 
neurons, and DRD3 (dopamine D3 receptor 3). 
PICK1 also has a role in glutamate receptor 
regulation (Corominas et al., 2018). 
Disease 
ADHD is characterized by of lack of attention, 
impulsivity, hyperactivity and distractibility.  
It is a highly heritable (80%-90%) childhood 
behavioral disorder with a prevalence estimated at 5-
7% in children, male predominance, and half of them 
have persisting symptoms in adulthood.  
In addition to genetic factors, environmental factors 
(adverse circumstances in maternal or children life) 
have been implicated in the etiology of ADHD. 
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